4A49 - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   STRUCTURE OF PHOSPHOTYR371-C-CBL-UBCH5B COMPLEX

Authors :   H. Dou, L. Buetow, A. Hock, G. J. Sibbet, K. H. Vousden, D. T. Huang

Date :   07 Oct 11 (Deposition) - 25 Jan 12 (Release) - 29 Feb 12 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.21

Chains :   Asym./Biol. Unit : A,B

Keywords :   Ligase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   H. Dou, L. Buetow, A. Hock, G. J. Sibbet, K. H. Vousden, D. T. Huang
Structural Basis For Autoinhibition And Phosphorylation-Dependent Activation Of C-Cbl
Nat. Struct. Mol. Biol. V. 19 184 2012
PubMed-ID: 22266821 | Reference-DOI: 10.1038/NSMB.2231

Molecule 1 - E3 UBIQUITIN-PROTEIN LIGASE CBL
	Chains	:	A
	EC Number	:	6.3.2.-
	Fragment	:	C-CBL RESIDUES 354-435
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Other Details	:	TYR371 IS PHOSPHORYLATED
	Synonym	:	C-CBL, CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE, PROTO-ONCOGENE C-CBL, RING FINGER PROTEIN 55, SIGNAL TRANSDUCTION PROTEIN CBL

Molecule 2 - UBIQUITIN-CONJUGATING ENZYME E2 D2
	Chains	:	B
	EC Number	:	6.3.2.19
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	UBCH5B, UBIQUITIN CARRIER PROTEIN D2, UBIQUITIN-CONJUGATING ENZYME E2(17)KB 2, UBIQUITIN-CONJUGATING ENZYME E2-17 KDA 2, UBIQUITIN-PROTEIN LIGASE D2

		1	2
Asymmetric/Biological Unit	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (3, 4)

No.	Name	Count	Type	Full Name
1	K	1	Ligand/Ion	POTASSIUM ION
2	PTR	1	Mod. Amino Acid	O-PHOSPHOTYROSINE
3	ZN	2	Ligand/Ion	ZINC ION

Asymmetric Unit (3, 3)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	CYS A:381 , CYS A:384 , CYS A:401 , CYS A:404	BINDING SITE FOR RESIDUE ZN A1436
2	AC2	SOFTWARE	CYS A:396 , HIS A:398 , CYS A:416 , CYS A:419	BINDING SITE FOR RESIDUE ZN A1437
3	AC3	SOFTWARE	HIS B:7	BINDING SITE FOR RESIDUE K B1148

(no "SS Bond" information available for 4A49)

Asymmetric/Biological Unit

No.	Residues
1	Glu A:394	-	Pro A:395
2	Tyr B:60	-	Pro B:61

Asymmetric/Biological Unit (5, 5)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_064332	Q	367	P	CBL_HUMAN	Disease (NSLL)	267606704	A	Q	367	P
2	UniProt	VAR_071042	Y	371	H	CBL_HUMAN	Unclassified	267606706	A	Y	371	H
3	UniProt	VAR_064333	K	382	E	CBL_HUMAN	Disease (NSLL)	267606705	A	K	382	E
4	UniProt	VAR_064334	D	390	Y	CBL_HUMAN	Disease (NSLL)	267606707	A	D	390	Y
5	UniProt	VAR_064335	R	420	Q	CBL_HUMAN	Disease (NSLL)	267606708	A	R	420	Q

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (4, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	UBIQUITIN_CONJUGAT_2	PS50127	Ubiquitin-conjugating enzymes family profile.	UB2D2_HUMAN	4-136	1	B:4-136
2	UBIQUITIN_CONJUGAT_1	PS00183	Ubiquitin-conjugating enzymes active site.	UB2D2_HUMAN	74-89	1	B:74-89
3	ZF_RING_2	PS50089	Zinc finger RING-type profile.	CBL_HUMAN	381-420	1	A:381-420
4	ZF_RING_1	PS00518	Zinc finger RING-type signature.	CBL_HUMAN	396-405	1	A:396-405

Asymmetric/Biological Unit (10, 10)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1	ENST00000264033	1	ENSE00001240819	chr11:119076752-119077322	571	CBL_HUMAN	1-65	65	0	-	-
1.2	ENST00000264033	2	ENSE00001240799	chr11:119103158-119103405	248	CBL_HUMAN	66-148	83	0	-	-
1.3	ENST00000264033	3	ENSE00001240795	chr11:119142445-119142591	147	CBL_HUMAN	148-197	50	0	-	-
1.4	ENST00000264033	4	ENSE00001240790	chr11:119144578-119144734	157	CBL_HUMAN	197-249	53	0	-	-
1.5	ENST00000264033	5	ENSE00001240782	chr11:119145542-119145663	122	CBL_HUMAN	250-290	41	0	-	-
1.6	ENST00000264033	6	ENSE00001240776	chr11:119146707-119146844	138	CBL_HUMAN	290-336	47	0	-	-
1.7	ENST00000264033	7	ENSE00001128289	chr11:119148467-119148554	88	CBL_HUMAN	336-365	30	1	A:359-365	7
1.8	ENST00000264033	8	ENSE00001795866	chr11:119148876-119149007	132	CBL_HUMAN	366-409	44	1	A:366-409	44
1.9	ENST00000264033	9	ENSE00001128273	chr11:119149220-119149423	204	CBL_HUMAN	410-477	68	1	A:410-435	26
1.10	ENST00000264033	10	ENSE00000796209	chr11:119155679-119155810	132	CBL_HUMAN	478-521	44	0	-	-
1.11	ENST00000264033	11	ENSE00001206751	chr11:119155899-119156276	378	CBL_HUMAN	522-647	126	0	-	-
1.12	ENST00000264033	12	ENSE00000796211	chr11:119158562-119158656	95	CBL_HUMAN	648-679	32	0	-	-
1.13	ENST00000264033	13	ENSE00000796212	chr11:119167628-119167744	117	CBL_HUMAN	679-718	40	0	-	-
1.14	ENST00000264033	14	ENSE00000796213	chr11:119168094-119168191	98	CBL_HUMAN	718-751	34	0	-	-
1.15	ENST00000264033	15	ENSE00000796214	chr11:119169068-119169250	183	CBL_HUMAN	751-812	62	0	-	-
1.16	ENST00000264033	16	ENSE00001238481	chr11:119170205-119177651	7447	CBL_HUMAN	812-906	95	0	-	-

2.2d	ENST00000398734	2d	ENSE00002067174	chr5:138941311-138941400	90	UB2D2_HUMAN	1-8	8	1	B:2-8	7
2.6a	ENST00000398734	6a	ENSE00001727928	chr5:138979957-138980020	64	UB2D2_HUMAN	9-30	22	1	B:9-30	22
2.7a	ENST00000398734	7a	ENSE00000898561	chr5:138994171-138994202	32	UB2D2_HUMAN	30-40	11	1	B:30-40	11
2.8	ENST00000398734	8	ENSE00001673964	chr5:138994282-138994359	78	UB2D2_HUMAN	41-66	26	1	B:41-66	26
2.9	ENST00000398734	9	ENSE00001785808	chr5:138994446-138994551	106	UB2D2_HUMAN	67-102	36	1	B:67-102	36
2.10b	ENST00000398734	10b	ENSE00001694979	chr5:139002953-139003046	94	UB2D2_HUMAN	102-133	32	1	B:102-133	32
2.11b	ENST00000398734	11b	ENSE00002035469	chr5:139006341-139006642	302	UB2D2_HUMAN	133-147	15	1	B:133-147	15
2.11f	ENST00000398734	11f	ENSE00002075824	chr5:139007137-139007271	135	UB2D2_HUMAN	-	0	0	-	-

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:77
 aligned with CBL_HUMAN | P22681 from UniProtKB/Swiss-Prot  Length:906

    Alignment length:77
                                   368       378       388       398       408       418       428       
            CBL_HUMAN   359 DHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPIVVDPFD 435
               SCOP domains ----------------------------------------------------------------------------- SCOP domains
               CATH domains ----------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eee.hhhhhhhhhhh................eeee....eehhhhhhhhhhh.............eeee.eee... Sec.struct. author
                 SAPs(SNPs) --------P---H----------E-------Y-----------------------------Q--------------- SAPs(SNPs)
                PROSITE (1) ----------------------ZF_RING_2  PDB: A:381-420               --------------- PROSITE (1)
                PROSITE (2) -------------------------------------ZF_RING_1 ------------------------------ PROSITE (2)
               Transcript 1 1.7    Exon 1.8  PDB: A:366-409 UniProt: 366-409   Exon 1.9  PDB: A:410-435   Transcript 1
                 4a49 A 359 DHIKVTQEQFELyCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPIVVDPFD 435
                                   368  |    378       388       398       408       418       428       
                                      371-PTR

Chain B from PDB  Type:PROTEIN  Length:146
 aligned with UB2D2_HUMAN | P62837 from UniProtKB/Swiss-Prot  Length:147

    Alignment length:146
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141      
          UB2D2_HUMAN     2 ALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM 147
               SCOP domains d4a49b_ B: Ubiquitin conjugating enzyme, UBC                                                                                                       SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhh....eeeeee..eeeeeeeeee..........eeeeeee..........eeee................hhhhh.......hhhhhhhhhhhhhhh.......hhhhhhhhhhhhhhhhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) --UBIQUITIN_CONJUGAT_2  PDB: B:4-136 UniProt: 4-136                                                                                    ----------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------UBIQUITIN_CONJUG---------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) 2.2d   Exon 2.6a  PDB: B:9-30----------Exon 2.8  PDB: B:41-66    -----------------------------------Exon 2.10b  PDB: B:102-133      -------------- Transcript 2 (1)
           Transcript 2 (2) ----------------------------Exon 2.7a  --------------------------Exon 2.9  PDB: B:67-102             ------------------------------Exon 2.11b      Transcript 2 (2)
                 4a49 B   2 ALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM 147
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a+b) (23004)

Fold: UBC-like (176)

Superfamily: UBC-like (176)

Family: UBC-related (135)

Protein domain: Ubiquitin conjugating enzyme, UBC (84)

Human (Homo sapiens), ubch5b [TaxId: 9606] (11)

d4a49b_

(no "CATH Domain" information available for 4A49)

(no "Pfam Domain" information available for 4A49)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (CBL_HUMAN | P22681)

molecular function
	GO:0017124	SH3 domain binding	Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0046875	ephrin receptor binding	Interacting selectively and non-covalently with an ephrin receptor.
	GO:0016874	ligase activity	Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0001784	phosphotyrosine residue binding	Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0019901	protein kinase binding	Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
	GO:0004871	signal transducer activity	Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
	GO:0003700	transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0061630	ubiquitin protein ligase activity	Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.
	GO:0004842	ubiquitin-protein transferase activity	Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0007166	cell surface receptor signaling pathway	A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0007173	epidermal growth factor receptor signaling pathway	A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0048260	positive regulation of receptor-mediated endocytosis	Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
	GO:0016567	protein ubiquitination	The process in which one or more ubiquitin groups are added to a protein.
	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	The process in which a ubiquitin group, or multiple groups, are covalently attached to the target protein, thereby initiating the degradation of that protein.
	GO:0023051	regulation of signaling	Any process that modulates the frequency, rate or extent of a signaling process.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0007179	transforming growth factor beta receptor signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0016600	flotillin complex	A protein complex that contains flotillin-1 and flotillin-2, and may contain associated proteins. Flotillins associate into membrane microdomains resembling caveolae.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain B (UB2D2_HUMAN | P62837)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0061631	ubiquitin conjugating enzyme activity	Isoenergetic transfer of ubiquitin from one protein to another via the reaction X-ubiquitin + Y -> Y-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue.
	GO:0004842	ubiquitin-protein transferase activity	Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
biological process
	GO:0038095	Fc-epsilon receptor signaling pathway	A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.
	GO:0050852	T cell receptor signaling pathway	A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
	GO:0006464	cellular protein modification process	The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
	GO:0070936	protein K48-linked ubiquitination	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation.
	GO:0051865	protein autoubiquitination	The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink.
	GO:0000209	protein polyubiquitination	Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain.
	GO:0016567	protein ubiquitination	The process in which one or more ubiquitin groups are added to a protein.
	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0002223	stimulatory C-type lectin receptor signaling pathway	Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.
	GO:0006511	ubiquitin-dependent protein catabolic process	The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.
cellular component
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
	GO:0000151	ubiquitin ligase complex	A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		K	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PTR	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Glu A:394 - Pro A:395	[ RasMol ]
		Tyr B:60 - Pro B:61	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	4a49
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	CBL_HUMAN \| P22681
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt
	UB2D2_HUMAN \| P62837
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	6.3.2.-
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc
	6.3.2.19
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	613563
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	CBL_HUMAN \| P22681
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)
	UB2D2_HUMAN \| P62837
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1b47	STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70
1fbv	STRUCTURE OF A CBL-UBCH7 COMPLEX: RING DOMAIN FUNCTION INUBIQUITIN-PROTEIN LIGASES
1ur6	NMR BASED STRUCTURAL MODEL OF THE UBCH5B-CNOT4 COMPLEX
1w4u	NMR SOLUTION STRUCTURE OF THE UBIQUITIN CONJUGATING ENZYME UBCH5B
1yvh	CRYSTAL STRUCTURE OF THE C-CBL TKB DOMAIN IN COMPLEX WITHTHE APS PTYR-618 PHOSPHOPEPTIDE
2c4o	CRYSTAL STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBCH5B
2cbl	N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70
2clw	CRYSTAL STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBCH5B
2esk	HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B, WILD- TYPE
2eso	HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTILE37ALA
2esp	HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTILE88ALA
2esq	HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANTSER94GLY
2y1m	STRUCTURAL BASIS FOR AUTOINHIBITION AND PHOSPHORYLATION- DEPENDENTACTIVATION OF C-CBL: NATIVE C-CBL.
2y1n	STRUCTURAL BASIS FOR AUTOINHIBITION AND PHOSPHORYLATION- DEPENDENTACTIVATION OF C-CBL: C-CBL-ZAP-70 PEPTIDE COMPLEX.
4a4b	STRUCTURE OF MODIFIED PHOSPHOTYR371-C-CBL-UBCH5B-ZAP- 70 COMPLEX
4a4c	STRUCTURE OF PHOSPHOTYR371-C-CBL-UBCH5B-ZAP-70 COMPLEX

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 4)

Sites (3, 3)

SS Bonds (0, 0)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (5, 5)

PROSITE Motifs (4, 4)

Exons (10, 10)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (50, 54)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File